Example: dental hygienist
PRESS RELEASE - camel-ids.com
PRESS RELEASE 1 Camel-IDS completes EUR 37m Series A financing to develop cancer-targeted radiopharmaceuticals • Camel-IDS is developing new radiopharmaceuticals based on linking single domain antibody fragments with radioisotopes to treat cancer
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: